Hyasat Kais, Su Chieh-Shou, Kirtane Ajay J, McEntegart Margaret
Department of Cardiology, Columbia University Irving Medical Center/New York Presbyterian Hospital and the Cardiovascular Research Foundation, 161 Fort Washington Avenue, New York, NY 10032, United States of America.
Department of Cardiology, Columbia University Irving Medical Center/New York Presbyterian Hospital and the Cardiovascular Research Foundation, 161 Fort Washington Avenue, New York, NY 10032, United States of America; Cardiovascular Center, Taichung Veterans General Hospital, Taichung, Taiwan.
Prog Cardiovasc Dis. 2025 Jan-Feb;88:105-112. doi: 10.1016/j.pcad.2024.12.007. Epub 2024 Dec 30.
Ischemic cardiomyopathy (ICM) is characterized by myocardial dysfunction due to myocardial ischemia, associated with the presence of significant coronary artery disease (CAD). We provide a comprehensive review of the current evidence for coronary revascularization in ICM, including consideration of the different modalities of coronary artery bypass grafting and percutaneous coronary intervention. In addition to a contemporary assessment of the literature, we aim to provide real-world insights and perspectives to guide clinical decision-making in this heterogeneous and complex patient population.
缺血性心肌病(ICM)的特征是由于心肌缺血导致心肌功能障碍,并伴有严重冠状动脉疾病(CAD)。我们对ICM中冠状动脉血运重建的现有证据进行了全面综述,包括对冠状动脉旁路移植术和经皮冠状动脉介入治疗等不同方式的考量。除了对文献进行当代评估外,我们旨在提供实际见解和观点,以指导对这一异质性和复杂患者群体的临床决策。